Found 0 matching trials
Conversion Therapy of Sintilimab in Combination With Apatinib and Chemotherapy in Stage IV Gastric Cancer PHASE2 This is a single-arm, phase II study aiming to evaluate the feasibility and...
Show More Location
Department of Gastric Surgery, Tianjin Medical University Cancer Institute and Hospital
Learn More & Join Trial
Anti-PD-1 Antibody Plus Regorafenib in Refractory Microsatellite Stable Metastatic Colorectal Cancer N/A Managements for refractory proficient mismatch repair (pMMR) or microsatell...
Show More Location
Hunan Cancer hospital
Learn More & Join Trial
Assessing the Tolerance and Clinical Benefit of feCAl tranSplantation in patientS With melanOma PHASE2 Recent studies suggest that patients with metastatic melanoma whose gut mic...
Show More Learn More & Join Trial
Carboplatin-paclitaxel With Retifanlimab or Placebo in Participants With Locally Advanced or Metastatic Squamous Cell Anal Carcinoma (POD1UM-303/InterAACT 2). PHASE3 This study is a Phase 3 global, multicenter, placebo-controlled double-blin...
Show More Location
The University of Arizona Cancer Center
Learn More & Join Trial
Electro-Acupuncture in Lung cancER : EALER Study NA This multicentre, randomized controlled trial evaluates the effect and safe...
Show More Location
Guangdong Provincial Hospital of Chinese Medicine
Learn More & Join Trial
Sintilimab Plus Bevacizumab in Recurrent/Persistent Ovarian Clear Cell Carcinoma PHASE2 Ovarian clear cell carcinoma (OCCC) is one of the rare subtypes of ovarian ...
Show More Location
Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
HAIC Combined With Lenvatinib and PD-1 Inhibitor in Infiltrative Hepatocellular Carcinoma N/A Hepatic arterial infusion chemotherapy (HAIC) plus lenvatinib and programme...
Show More Location
Chinese PLA General hospital
Learn More & Join Trial
Genetically Engineered Cells (MAGE-A1-specific T Cell Receptor-transduced Autologous T-cells) and Atezolizumab for the Treatment of Metastatic Triple Negative Breast Cancer, Urothelial Cancer, or Non-small Cell Lung Cancer PHASE1 This phase I/II trial investigates the side effects of genetically engineer...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
BRIDGE Study: Neoadjuvant Finotonlimab, Cetuximab, and Docetaxel in Resectable Recurrent HNSCC After Immunotherapy Progression PHASE2 This is a multicenter, single-arm, phase II clinical study evaluating the e...
Show More Status
Enrolling By Invitation
Location
The First People's Hospital of Foshan
Learn More & Join Trial
Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Breast Cancer PHASE2 This is a phase II Randomized comparison clinical trial of activated CIK ar...
Show More Location
Institutional Review Board of Guangzhou Fuda Cancer Hospital
Learn More & Join Trial